Veterinary Vaccines Market Overview
Veterinary vaccines are used primarily for livestock, as they suffer from various diseases, like bluetongue virus, foot-and-mouth disease (FMD), and rabies. That’s result the companion vaccine is predicted to witness high growth, over the forecast period. Vaccination has long been a principal point of canine practice, because it is one among the safest and most cost-effective means of communicable disease prevention.
The trend is further expected to reinforce during the forecast period, due to the factors, like pet humanization, and therefore the rapid adoption of pets in emerging economies. The huge adoption of pets increases the vaccination programs of the companion animals boosting the segment growth. Advancement in diagnostic services and vaccine technology and the rapid proliferation of companion animal vaccines also a concern over vaccine safety has contributed to the strong growth of the segment. Moreover, the market is being positively suffering from evolving vaccine protocols with continuously changing patterns of diseases and therefore the pet population.
Covid-19 Impact on Veterinary Vaccines Market:
In addition, this Global Market study offers an thorough analysis of this COVID-19 pandemic impact on the market growth and its influence on the long run growth of the worldwide Market. The recently published report demonstrates the elevation within the demand for the healthcare sector. The healthcare manufacturers have experienced future also as short term effect which incorporates supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption might be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and makers to the limit. In addition to this, panic conditions have already spurred the demand for several healthcare products and services which are discussed intimately during this report. Moreover, the impact of this pandemic on overall market revenue for rock bottom year 2020 and its projection up to 2027 is provided intimately during this report.
Veterinary Vaccines Market Segment Overview
By vaccines type, the porcine vaccines market holds the major market share because increasing poultry segment.
By technology, toxoid vaccines holds the major market share in estimated time. This will be ascribed to the product’s impeccable benefits, like long-lasting immunity and high stability, immune response to original toxin, and fewer susceptibility to changes in humidity and temperature.
By animal type, changing people’s behaviours towards chicken and meat, that poultry segment dominated huge market demand in worldwide. Owing to this gradually impact on poultry segment vaccines.
Market Analysis, Insights and Forecast – By Vaccines Type
· Live Attenuated Vaccines
· Inactivated Vaccines
· Toxoid Vaccines
· Recombinant Vaccines
· Other
Veterinary Vaccines Market Regional Overview
Region-wise, in terms of regions, The Asia Pacific is predicted to grow at the best rate within the veterinary vaccines market. The expansion of this market include the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities in various Asia Pacific countries, especially in India, China, and Thailand.
Veterinary Vaccines Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Veterinary Vaccines Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Veterinary Vaccines are highlighted below.
· In 2020, Merck Animal Health signed a partnership agreement with Automazioni VX, Inc. The partnership results to achieve new technology which is on chick vaccination technology that covers against infectious diseases in poultry.
Veterinary Vaccines Market, Key Players
· Zoetis
· Merck Animal Health
· Boehringer Ingelheim
· Elanco
· Ceva
· Virbac
· Vetoquinol
· Phibro Animal Health
· Hester Biosciences
· HIPRA
· Biogenesis Bago
· Tianjin Ringpu
· China Animal Husbandry
· Jinyu Bio-technology
· Endovac Animal Health
Veterinary vaccines are used primarily for livestock, as they suffer from various diseases, like bluetongue virus, foot-and-mouth disease (FMD), and rabies. That’s result the companion vaccine is predicted to witness high growth, over the forecast period. Vaccination has long been a principal point of canine practice, because it is one among the safest and most cost-effective means of communicable disease prevention.
The trend is further expected to reinforce during the forecast period, due to the factors, like pet humanization, and therefore the rapid adoption of pets in emerging economies. The huge adoption of pets increases the vaccination programs of the companion animals boosting the segment growth. Advancement in diagnostic services and vaccine technology and the rapid proliferation of companion animal vaccines also a concern over vaccine safety has contributed to the strong growth of the segment. Moreover, the market is being positively suffering from evolving vaccine protocols with continuously changing patterns of diseases and therefore the pet population.
Covid-19 Impact on Veterinary Vaccines Market:
In addition, this Global Market study offers an thorough analysis of this COVID-19 pandemic impact on the market growth and its influence on the long run growth of the worldwide Market. The recently published report demonstrates the elevation within the demand for the healthcare sector. The healthcare manufacturers have experienced future also as short term effect which incorporates supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption might be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and makers to the limit. In addition to this, panic conditions have already spurred the demand for several healthcare products and services which are discussed intimately during this report. Moreover, the impact of this pandemic on overall market revenue for rock bottom year 2020 and its projection up to 2027 is provided intimately during this report.
Veterinary Vaccines Market Segment Overview
By vaccines type, the porcine vaccines market holds the major market share because increasing poultry segment.
By technology, toxoid vaccines holds the major market share in estimated time. This will be ascribed to the product’s impeccable benefits, like long-lasting immunity and high stability, immune response to original toxin, and fewer susceptibility to changes in humidity and temperature.
By animal type, changing people’s behaviours towards chicken and meat, that poultry segment dominated huge market demand in worldwide. Owing to this gradually impact on poultry segment vaccines.
Market Analysis, Insights and Forecast – By Vaccines Type
- Porcine Vaccines
- Poultry Vaccine
- Livestock Vaccine
- Bovine Vaccines
- Small Ruminant Vaccines
- Companion Animal Vaccine
- Canine Vaccine
- Feline Vaccine
- Aquaculture Vaccines
- Other
- Porcine
- Poultry
- Livestock
- Bovine
- Small Ruminant
- Companion Animal
- Canine
- Feline
- Aquaculture
· Live Attenuated Vaccines
· Inactivated Vaccines
· Toxoid Vaccines
· Recombinant Vaccines
· Other
Veterinary Vaccines Market Regional Overview
Region-wise, in terms of regions, The Asia Pacific is predicted to grow at the best rate within the veterinary vaccines market. The expansion of this market include the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities in various Asia Pacific countries, especially in India, China, and Thailand.
Veterinary Vaccines Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Veterinary Vaccines Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Veterinary Vaccines are highlighted below.
· In 2020, Merck Animal Health signed a partnership agreement with Automazioni VX, Inc. The partnership results to achieve new technology which is on chick vaccination technology that covers against infectious diseases in poultry.
Veterinary Vaccines Market, Key Players
· Zoetis
· Merck Animal Health
· Boehringer Ingelheim
· Elanco
· Ceva
· Virbac
· Vetoquinol
· Phibro Animal Health
· Hester Biosciences
· HIPRA
· Biogenesis Bago
· Tianjin Ringpu
· China Animal Husbandry
· Jinyu Bio-technology
· Endovac Animal Health
Veterinary Vaccines Market Study Global Market Analysis, Insights and Forecast, 2020-20275.4. Market Analysis, Insights and Forecast – By Region 6.4. Market Analysis, Insights and Forecast – By Country 7.4. Market Analysis, Insights and Forecast – By Country 8.4. Market Analysis, Insights and Forecast – By Country 9.4. Market Analysis, Insights and Forecast – By Country
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Veterinary Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Vaccines Type
- 5.2.1. Ectoparasiticides
- 5.2.1.1. Oral Tablets
- 5.2.1.2. Dips
- 5.2.1.3. Spray
- 5.2.1.4. Spot-on
- 5.2.1.5. Others
- 5.2.2. Endoparasiticides
- 5.2.2.1. Oral Suspension
- 5.2.2.2. Injectable
- 5.2.2.3. Feed Additives
- 5.2.2.4. Others
- 5.2.3. Endectocides
- 5.2.1. Ectoparasiticides
- 5.3. Market Analysis, Insights and Forecast – By Animal Type
- 5.3.1. Food-Producing Animals
- 5.3.1.1. Cattle
- 5.3.1.2. Poultry
- 5.3.1.3. Swine
- 5.3.1.4. Others
- 5.3.2. Companion Animals
- 5.3.2.1. Dogs
- 5.3.2.2. Felines
- 5.3.2.3. Others
- 5.3.1. Food-Producing Animals
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East, and Africa
6. North America Veterinary Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Vaccines Type
- 6.2.1. Ectoparasiticides
- 6.2.1.1. Oral Tablets
- 6.2.1.2. Dips
- 6.2.1.3. Spray
- 6.2.1.4. Spot-on
- 6.2.1.5. Others
- 6.2.2. Endoparasiticides
- 6.2.2.1. Oral Suspension
- 6.2.2.2. Injectable
- 6.2.2.3. Feed Additives
- 6.2.2.4. Others
- 6.2.3. Endectocides
- 6.2.1. Ectoparasiticides
- 6.3. Market Analysis, Insights and Forecast – By Animal Type
- 6.3.1. Food-Producing Animals
- 6.3.1.1. Cattle
- 6.3.1.2. Poultry
- 6.3.1.3. Swine
- 6.3.1.4. Others
- 6.3.2. Companion Animals
- 6.3.2.1. Dogs
- 6.3.2.2. Felines
- 6.3.2.3. Others
- 6.3.1. Food-Producing Animals
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Veterinary Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Vaccines Type
- 7.2.1. Ectoparasiticides
- 7.2.1.1. Oral Tablets
- 7.2.1.2. Dips
- 7.2.1.3. Spray
- 7.2.1.4. Spot-on
- 7.2.1.5. Others
- 7.2.2. Endoparasiticides
- 7.2.2.1. Oral Suspension
- 7.2.2.2. Injectable
- 7.2.2.3. Feed Additives
- 7.2.2.4. Others
- 7.2.3. Endectocides
- 7.2.1. Ectoparasiticides
- 7.3. Market Analysis, Insights and Forecast – By Animal Type
- 7.3.1. Food-Producing Animals
- 7.3.1.1. Cattle
- 7.3.1.2. Poultry
- 7.3.1.3. Swine
- 7.3.1.4. Others
- 7.3.2. Companion Animals
- 7.3.2.1. Dogs
- 7.3.2.2. Felines
- 7.3.2.3. Others
- 7.3.1. Food-Producing Animals
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Veterinary Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Vaccines Type
- 8.2.1. Ectoparasiticides
- 8.2.1.1. Oral Tablets
- 8.2.1.2. Dips
- 8.2.1.3. Spray
- 8.2.1.4. Spot-on
- 8.2.1.5. Others
- 8.2.2. Endoparasiticides
- 8.2.2.1. Oral Suspension
- 8.2.2.2. Injectable
- 8.2.2.3. Feed Additives
- 8.2.2.4. Others
- 8.2.3. Endectocides
- 8.2.1. Ectoparasiticides
- 8.3. Market Analysis, Insights and Forecast – By Animal Type
- 8.3.1. Food-Producing Animals
- 8.3.1.1. Cattle
- 8.3.1.2. Poultry
- 8.3.1.3. Swine
- 8.3.1.4. Others
- 8.3.2. Companion Animals
- 8.3.2.1. Dogs
- 8.3.2.2. Felines
- 8.3.2.3. Others
- 8.3.1. Food-Producing Animals
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Veterinary Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Vaccines Type
- 9.2.1. Ectoparasiticides
- 9.2.1.1. Oral Tablets
- 9.2.1.2. Dips
- 9.2.1.3. Spray
- 9.2.1.4. Spot-on
- 9.2.1.5. Others
- 9.2.2. Endoparasiticides
- 9.2.2.1. Oral Suspension
- 9.2.2.2. Injectable
- 9.2.2.3. Feed Additives
- 9.2.2.4. Others
- 9.2.3. Endectocides
- 9.2.1. Ectoparasiticides
- 9.3. Market Analysis, Insights and Forecast – By Animal Type
- 9.3.1. Food-Producing Animals
- 9.3.1.1. Cattle
- 9.3.1.2. Poultry
- 9.3.1.3. Swine
- 9.3.1.4. Others
- 9.3.2. Companion Animals
- 9.3.2.1. Dogs
- 9.3.2.2. Felines
- 9.3.2.3. Others
- 9.3.1. Food-Producing Animals
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Zoetis
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Merck Animal Health
- 10.6. Boehringer Ingelheim
- 10.7. Elanco
- 10.8. Ceva
- 10.9. Virbac
- 10.10. Vetoquinol
- 10.11. Phibro Animal Health
- 10.12. Hester Biosciences
- 10.13. HIPRA
- 10.14. Biogenesis Bago
- 10.15. Tianjin Ringpu
- 10.16. China Animal Husbandry
- 10.17. Jinyu Bio-technology